Tag Archives: Omadacyline

Omadacyline Now Available in IV, Oral Forms for CABP, ABSSSI

February 08, 2019 This article originally appeared here. Share this content: Paratek also announced the availability of 3 FDA-approved antimicrobial susceptibility tests. Paratek announced the launch of Nuzyra (omadacycline) for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). It is the first once-daily antibiotic approved to… Read More »